Pacritinib Effectiveness in Real-world Settings

ClinicalTrials.gov ID: NCT07774455

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07774455. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pacritinib Effectiveness in Real-world Settings (PACER)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study aims to evaluate real-world treatment patterns and effectiveness of pacritinib, including hematologic and clinical outcomes, and survival through a site-based retrospective chart review of medical records of patients with MF.

Study identification

NCT ID: NCT07774455
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Swedish Orphan Biovitrum; Industry
Enrollment: 60 participants

Conditions and interventions

Conditions

Myelofibrosis (MF)

Interventions

Not applicable- observational study Other

Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 13, 2026 (Actual)
Primary completion: Mar 10, 2027 (Estimated)
Completion: Mar 10, 2027 (Estimated)
Last update posted: Oct 21, 2026

2026 – 2027

United States locations

U.S. sites: 5
U.S. states: 5
U.S. cities: 5

Facility	City	State	ZIP	Site status
Yale School of Medicine	New Haven	Connecticut	06511	Recruiting
Tampa General Hospital	Tampa	Florida	33606	Recruiting
The Ohio State University	Columbus	Ohio	43210	Recruiting
Medical University of South Carolina	Charleston	South Carolina	29425	Recruiting
OneOncology Research Network	Nashville	Tennessee	37219	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07774455, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 21, 2026 · Synced Nov 15, 2026